Project Grant H8G48880

The National Science Foundation (NSF) awarded a $997,689 Cooperative Agreement under its NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Omnicyte LLC, a minority-owned small business in Branford, CT. The funding supports the design and production of a next-generation COVID-19 vaccine that addresses weaknesses of current vaccines, such as reduced booster effectiveness, short-lived efficacy, and side effects. The project aims to develop a vaccine candidate with improved...

This $3,056,673 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to investigate the immunological mechanisms that contribute to improved antibody response rates in people living with HIV (PLWH) when vaccinated with the Heplisav-B hepatitis B vaccine compared to the standard Engerix-B vaccine. The study has three key objectives: Define the innate immune signatures, including...

This Project Grant award, provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), will fund a comprehensive study on the impact of minor vaccine consent (VC) laws on COVID-19 vaccine uptake and transmission among adolescents. The $1,266,296 award, effective from September 16, 2024 to March 10, 2025, will support the University of Pittsburgh's research team in developing a legal...

This federal Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Public Health Emergency Response: Cooperative Agreement for Emergency Response (CFDA 93.354) program provides $5,358,220.00 in funding to the Hawaii Department of Health Children With Special Health Needs - NBS Division. The award's goal is to increase vaccination rates in Hawaii, with a focused effort to boost education and vaccine coverage in populations disproportionately affected by...

This is a Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Strengthening Public Health through Surveillance, Epidemiologic Research, Disease Detection and Prevention program (CFDA 93.326). The award, valued at $18,893,037, was made to Beth Israel Deaconess Medical Center, Inc. (Bidmc) for a prospective observational study of respiratory virus epidemiology in the Greater Boston area. The study will span 5 years, from Aug 1, 2024 to Jul 31, 2029....

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $1,438,543 Cooperative Agreement to the Executive Office of the Governor of Delaware's Division of Public Health under the "Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects" (CFDA 93.185) program. This 5-year award, running from August 1, 2024 to July 31, 2029, will support the Division's comprehensive public health initiatives related to...

The U.S. Department of Agriculture's National Institute of Food and Agriculture (USDA-NIFA) awarded a $9.5M project grant under the Extension Collaborative on Immunization Teaching & Engagement (EXCITE) program to the Extension Foundation. This grant, spanning from Sep 2024 to May 2027, aims to stabilize and increase routine immunization rates in rural and underserved communities. The key objectives are to: 1) increase public confidence in adult vaccinations through collaboration with...

This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to New York University School of Medicine aims to synergize neutralizing and non-neutralizing antibody targets at the HIV/SIV viral spike apex to develop an improved HIV vaccine. The $228,825 award, active from Aug 2024 to Jun 2026, will 1) design and validate a V2B-focused immunogen, and 2) test the combination of vaccine-elicited anti-V2B...

This federal Project Grant award of $360,000 from the National Science Foundation's (NSF) Division of Mathematical Sciences and the CDC Coronavirus and Other Respiratory Viruses Division aims to improve policymaking processes for mitigating the transmission of respiratory pathogens, such as during the COVID-19 pandemic. The principal investigators will develop and study game theoretical mathematical models, simulation tools, and numerical approaches that can be adapted to specific public...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323) provides $799,904.00 in funding to New York University School of Medicine to establish an ARISE Coordinating and Collaborating Center for the Study of Vaccine Hesitancy and Uptake. The award, with a performance period of September 30, 2024 to September 29, 2029, will support research and coordination...